Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2024-01-30
Product name:
BUPRIXA
Description:
MULTIDOSE VIAL
DIN:
02542536
Product Monograph/Veterinary Labelling:
Date:
2023-12-14
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ZOETIS CANADA INC
16740 Trans Canada Highway
Kirkland
Quebec
Canada
H9H 4M7
Class:
Veterinary
Species:
Cats
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0142241005
| Active ingredient(s) | Strength |
|---|---|
| BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) | 0.3 MG / ML |